U.S. markets close in 5 hours 57 minutes
  • S&P 500

    4,175.37
    -10.10 (-0.24%)
     
  • Dow 30

    34,071.95
    -128.72 (-0.38%)
     
  • Nasdaq

    14,010.62
    -41.72 (-0.30%)
     
  • Russell 2000

    2,255.78
    -6.89 (-0.30%)
     
  • Crude Oil

    63.54
    +0.41 (+0.65%)
     
  • Gold

    1,772.60
    -7.60 (-0.43%)
     
  • Silver

    25.86
    -0.24 (-0.92%)
     
  • EUR/USD

    1.2031
    +0.0050 (+0.42%)
     
  • 10-Yr Bond

    1.6140
    +0.0410 (+2.61%)
     
  • GBP/USD

    1.3959
    +0.0120 (+0.86%)
     
  • USD/JPY

    108.2340
    -0.5490 (-0.50%)
     
  • BTC-USD

    56,549.17
    +1,660.27 (+3.02%)
     
  • CMC Crypto 200

    1,282.53
    -16.43 (-1.26%)
     
  • FTSE 100

    7,007.78
    -11.75 (-0.17%)
     
  • Nikkei 225

    29,685.37
    +2.00 (+0.01%)
     

CAH vs. ALGN: Which Stock Should Value Investors Buy Now?

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Cardinal Health (CAH) and Align Technology (ALGN). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.

The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The proven Zacks Rank emphasizes companies with positive estimate revision trends, and our Style Scores highlight stocks with specific traits.

Cardinal Health and Align Technology are both sporting a Zacks Rank of # 2 (Buy) right now. The Zacks Rank favors stocks that have recently seen positive revisions to their earnings estimates, so investors should rest assured that both of these companies have improving earnings outlooks. But this is only part of the picture for value investors.

Value investors analyze a variety of traditional, tried-and-true metrics to help find companies that they believe are undervalued at their current share price levels.

Our Value category grades stocks based on a number of key metrics, including the tried-and-true P/E ratio, the P/S ratio, earnings yield, and cash flow per share, as well as a variety of other fundamentals that value investors frequently use.

CAH currently has a forward P/E ratio of 9.36, while ALGN has a forward P/E of 102.81. We also note that CAH has a PEG ratio of 1.72. This figure is similar to the commonly-used P/E ratio, with the PEG ratio also factoring in a company's expected earnings growth rate. ALGN currently has a PEG ratio of 5.62.

Another notable valuation metric for CAH is its P/B ratio of 10.84. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities. By comparison, ALGN has a P/B of 12.42.

These are just a few of the metrics contributing to CAH's Value grade of B and ALGN's Value grade of F.

Both CAH and ALGN are impressive stocks with solid earnings outlooks, but based on these valuation figures, we feel that CAH is the superior value option right now.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Cardinal Health, Inc. (CAH) : Free Stock Analysis Report
 
Align Technology, Inc. (ALGN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.